All Articles

Chimeric antigen receptor (CAR) T-cell therapy could soon be added to the treatment armamentarium in relapsed/refractory multiple myeloma.

Go beyond just giving patients health information; make sure they understand it and are able to take action.

The path to fulfilling your professional role lies in your engagement in advocacy. Here’s a beginner’s guide to advocacy.

Altered sexuality and intimacy are among the top quality-of-life issues cited by cancer survivors posttreatment, according to Sage Bolte, PhD, LCSW, Chief Philanthropy Officer and President, Inova Health Foundation.

The American Cancer Society reports good news regarding the overall lower rate of cancer-related mortalities in the United States, but also points to some disturbing trends.

The FDA approval of avapritinib marks the first time a drug has been approved specifically for patients with GIST harboring PDGFRA exon 18 mutations, which are involved in approximately 10% of GIST cases.